A Clinical Study to Evaluate the Efficacy and Safety of CKD-351

NCT04448223 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: CKD-351
DRUG: Latanoprost+Dorzolmamide

Sponsor

Chong Kun Dang Pharmaceutical